Literature DB >> 8282372

Insulin sensitivity and the effects of insulin on renal sodium handling and pressor systems in essential hypertensive patients.

K Shimamoto1, A Hirata, M Fukuoka, K Higashiura, Y Miyazaki, M Shiiki, A Masuda, M Nakagawa, O Iimura.   

Abstract

Insulin resistance and hyperinsulinemia are linked with essential hypertension. To clarify insulin sensitivity in Japanese essential hypertensive patients and the role of insulin resistance in these patients, a euglycemic hyperinsulinemic glucose clamp was applied in 17 essential hypertensive patients and 12 normotensive subjects. The mean glucose infusion rate was used as an indicator of insulin sensitivity (M value). This study revealed a significantly lower M value in essential hypertensive patients than in normotensive subjects. Increased plasma norepinephrine, renin activity, and aldosterone levels were observed after hyperinsulinemia for 120 minutes after glucose clamp in normotensive subjects and essential hypertensive patients. Urinary sodium excretion and fractional excretion of sodium were decreased in essential hypertensive patients as well as normotensive subjects during glucose clamp compared with the period before glucose clamp. No difference in the percent change was observed between essential hypertensive patients and normotensive subjects. These results indicate that selective insulin resistance with respect to glucose metabolism exists in essential hypertensive patients and that insulin action on renal sodium handling and pressor systems was maintained in these patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282372     DOI: 10.1161/01.hyp.23.1_suppl.i29

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

Review 1.  Management of the insulin resistance syndrome.

Authors:  C Desouza; L Gilling; V Fonseca
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

2.  Sodium sensitivity of blood pressure in Chinese populations.

Authors:  Jing Chen
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

Review 3.  Epithelial Na+ channel (ENaC), hormones, and hypertension.

Authors:  James K Bubien
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

Review 4.  Targeting inflammation in metabolic syndrome.

Authors:  Francine K Welty; Abdulhamied Alfaddagh; Tarec K Elajami
Journal:  Transl Res       Date:  2015-07-03       Impact factor: 7.012

5.  Differential predictors of insulin resistance in nondiabetic salt-resistant and salt-sensitive subjects.

Authors:  Cheryl L Laffer; Fernando Elijovich
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

6.  Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study.

Authors:  Jing Chen; Dongfeng Gu; Jianfeng Huang; Dabeeru C Rao; Cashell E Jaquish; James E Hixson; Chung-Shiuan Chen; Jichun Chen; Fanghong Lu; Dongsheng Hu; Treva Rice; Tanika N Kelly; L Lee Hamm; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

Review 7.  Metabolic syndrome and associated chronic kidney diseases: nutritional interventions.

Authors:  P Anil Kumar; P Swathi Chitra; G Bhanuprakash Reddy
Journal:  Rev Endocr Metab Disord       Date:  2013-09       Impact factor: 6.514

Review 8.  Sodium sensitivity of blood pressure in Chinese populations.

Authors:  Yang Liu; Mengyao Shi; Jacquelyn Dolan; Jiang He
Journal:  J Hum Hypertens       Date:  2019-01-10       Impact factor: 3.012

9.  Small increases in plasma sodium are associated with higher risk of mortality in a healthy population.

Authors:  Se Won Oh; Seon Ha Baek; Jung Nam An; Ho Suk Goo; Sejoong Kim; Ki Young Na; Dong Wan Chae; Suhnggwon Kim; Ho Jun Chin
Journal:  J Korean Med Sci       Date:  2013-07-03       Impact factor: 2.153

10.  Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.

Authors:  Hidenori Nishida; Eisei Sohara; Naohiro Nomura; Motoko Chiga; Dario R Alessi; Tatemitsu Rai; Sei Sasaki; Shinichi Uchida
Journal:  Hypertension       Date:  2012-09-04       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.